Nagi Bioscience
We are a Swiss high-tech company developing and offering cutting-edge biological testing solutions that enable scientists to generate insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our technologies are designed to integrate seamlessly into existing lab environments, enhancing efficiency, accuracy, and reproducibility.
Particulate and drug-induced toxicity assessed in novel quadruple cell human primary hepatic disease models of steatosis and pre-fibrotic NASH
A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates
Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model
Sweet and sticky: increased cell adhesion through click-mediated functionalization of regenerative liver progenitor cells
4D live imaging and computational modeling of a functional gut-on-a-chip evaluate how peristalsis facilitates enteric pathogen invasion
Quris.AI
Quris.AI is transforming drug safety prediction by uniquely combining advanced AI capabilities with cutting edge 3D organ models, enabling predictions with unprecedented accuracy and scalability. our platform has been extensively validated by leading Pharma companies, including a long term collaboration with Merck GmbH. By predicting safety in human relevant 3D models, our platform significantly increases the likelihood of clinical success and reduces significantly the need for animal testing.
A new immortalized human alveolar epithelial cell model to study lung injury and toxicity on a breathing lung-on-chip system
Optics11
Optics11Life develops cutting-edge life science tools using optical fiber sensing technology. The two main products are: The Nanoindentation Platform (Pavone, Piuma and Chiaro) and The Cuore 3D Engineered Muscle Contractility Platform